Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...

BNB price grazed the $800 mark on Sunday, printing 7% gains in three consecutive days of trading. The Binance Coin rally coincides with Nasdaq-listed Windtree Therapeutics committing $520 million for ...

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, Warrington-based Windtree Therapeutics ...

Windtree Therapeutics' latest move goes beyond its surprising forays into real estate and waste management, as the company ...